ArticleHepatology (Baltimore, Md.)2015

CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.

Yunching Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.